| PFR | Isoform Accession | Modifications | Length | Confidence |
|---|---|---|---|---|
| 163034 | Q5VTE0 | 37 | ![]() |
|
| 163035 | Q5VTE0 | 36 | ![]() |
|
| 163036 | Q5VTE0 | 40 | ![]() |
|
| 163037 | Q5VTE0 | 30 | ![]() |
|
| 163038 | Q5VTE0 | 35 | ![]() |
|
| 163039 | Q5VTE0 | 5-L-glutamyl glycerylphosphorylethanolamine@301 | 41 | ![]() |
| 163040 | Q5VTE0 | 47 | ![]() |
|
| 163041 | Q5VTE0 | 28 | ![]() |
|
| 163042 | Q5VTE0 | 27 | ![]() |
|
| 163043 | Q5VTE0 | 30 | ![]() |
|
| 163044 | Q5VTE0 | 22 | ![]() |
|
| 163045 | Q5VTE0 | 32 | ![]() |
|
| 163046 | Q5VTE0 | 34 | ![]() |
|
| 163047 | Q5VTE0 | 40 | ![]() |
|
| 163048 | Q5VTE0 | 20 | ![]() |
|
| 163049 | Q5VTE0 | 5-L-glutamyl glycerylphosphorylethanolamine@301 | 31 | ![]() |
| 163050 | Q5VTE0 | 5-L-glutamyl glycerylphosphorylethanolamine@301 | 46 | ![]() |
| 163051 | Q5VTE0 | 36 | ![]() |
|
| 163052 | Q5VTE0 | 40 | ![]() |
|
| 163053 | Q5VTE0 | 27 | ![]() |